| Breakdown | Mar 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 554.25B | 530.88B | 513.54B | 556.57B | 432.78B |
| Gross Profit | 74.74B | 74.78B | 74.32B | 65.62B | 56.99B |
| EBITDA | 28.64B | 29.79B | 30.17B | 25.61B | 20.58B |
| Net Income | 23.99B | 12.85B | 15.15B | 11.16B | 8.60B |
Balance Sheet | |||||
| Total Assets | 451.19B | 388.24B | 393.38B | 374.45B | 344.51B |
| Cash, Cash Equivalents and Short-Term Investments | 19.39B | 17.15B | 20.43B | 13.04B | 9.98B |
| Total Debt | 127.52B | 98.30B | 104.62B | 111.82B | 97.83B |
| Total Liabilities | 229.18B | 190.15B | 200.82B | 203.03B | 180.19B |
| Stockholders Equity | 210.22B | 187.15B | 182.62B | 162.56B | 156.23B |
Cash Flow | |||||
| Free Cash Flow | -18.82B | 5.69B | 21.95B | -6.83B | -36.77B |
| Operating Cash Flow | 10.46B | 21.17B | 36.72B | 398.00M | -26.63B |
| Investing Cash Flow | -9.83B | -9.59B | -16.08B | -5.59B | -9.33B |
| Financing Cash Flow | 8.23B | -13.88B | -14.59B | 5.79B | 34.47B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥41.67B | 15.11 | ― | 2.55% | 1.47% | 15.57% | |
69 Neutral | ¥18.85B | 1.94 | ― | 2.54% | 5.51% | 386.06% | |
65 Neutral | ¥31.09B | 9.22 | ― | 2.23% | 0.71% | -9.71% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
60 Neutral | ¥162.68B | 6.11 | 12.56% | 3.44% | 4.40% | 91.05% | |
58 Neutral | ¥65.00B | 13.66 | ― | 3.77% | -1.82% | -32.12% | |
51 Neutral | ¥293.82B | 28.13 | ― | 1.45% | 15.06% | 399.49% |